GB0904904D0 - Angiogenesis methods, medicaments and agents - Google Patents
Angiogenesis methods, medicaments and agentsInfo
- Publication number
- GB0904904D0 GB0904904D0 GBGB0904904.0A GB0904904A GB0904904D0 GB 0904904 D0 GB0904904 D0 GB 0904904D0 GB 0904904 A GB0904904 A GB 0904904A GB 0904904 D0 GB0904904 D0 GB 0904904D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- medicaments
- agents
- angiogenesis
- methods
- angiogenesis methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/531—Stem-loop; Hairpin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Vascular Medicine (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0904904.0A GB0904904D0 (en) | 2009-03-23 | 2009-03-23 | Angiogenesis methods, medicaments and agents |
PCT/GB2010/000516 WO2010109168A2 (en) | 2009-03-23 | 2010-03-23 | Angiogenesis methods, medicaments and agents |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0904904.0A GB0904904D0 (en) | 2009-03-23 | 2009-03-23 | Angiogenesis methods, medicaments and agents |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0904904D0 true GB0904904D0 (en) | 2009-05-06 |
Family
ID=40639952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0904904.0A Ceased GB0904904D0 (en) | 2009-03-23 | 2009-03-23 | Angiogenesis methods, medicaments and agents |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0904904D0 (en) |
WO (1) | WO2010109168A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103403187A (en) * | 2011-01-18 | 2013-11-20 | 艾沃锐斯特基因有限公司 | Prognostic signature for colorectal cancer recurrence |
CN108085336A (en) * | 2016-11-21 | 2018-05-29 | 中国科学院上海生命科学研究院 | EGFP expression vector establishments based on col2a1 promoters and the application in transgenic zebrafish |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
US5116742A (en) | 1986-12-03 | 1992-05-26 | University Patents, Inc. | RNA ribozyme restriction endoribonucleases and methods |
US5168053A (en) | 1989-03-24 | 1992-12-01 | Yale University | Cleavage of targeted RNA by RNAase P |
US5149796A (en) | 1989-08-31 | 1992-09-22 | City Of Hope | Chimeric DNA-RNA catalytic sequences |
US5180818A (en) | 1990-03-21 | 1993-01-19 | The University Of Colorado Foundation, Inc. | Site specific cleavage of single-stranded dna |
WO1995032425A1 (en) | 1994-05-23 | 1995-11-30 | Smithkline Beecham Corporation | Encoded combinatorial libraries |
US6225118B1 (en) | 1997-10-01 | 2001-05-01 | Biocure Limited | Multicellular in vitro assay of angiogenesis |
WO2008147528A1 (en) * | 2007-05-24 | 2008-12-04 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of modulating angiogenesis |
-
2009
- 2009-03-23 GB GBGB0904904.0A patent/GB0904904D0/en not_active Ceased
-
2010
- 2010-03-23 WO PCT/GB2010/000516 patent/WO2010109168A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2010109168A3 (en) | 2015-08-27 |
WO2010109168A2 (en) | 2010-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0917044D0 (en) | Agents, uses and methods | |
GB0917054D0 (en) | Agents, uses and methods | |
GB0916335D0 (en) | Medicaments | |
IL222930A0 (en) | Chlorotoxin variants, conjugates and methods for their use | |
EP2518147A4 (en) | Diacylglycerole acyltranferase gene, and use thereof | |
GB0908957D0 (en) | Therapeutic agents | |
HK1167597A1 (en) | Dodeca-2e,4e-diene amides and their use as medicaments and cosmetics -2e4e- | |
IL220526A0 (en) | Kokumi-imparting agent | |
EP2478768A4 (en) | Anti-plant-virus agent | |
ZA201209595B (en) | N-acetyl-dl-leucine, neuroprotective and retinoprotective medicament | |
IL220527A0 (en) | Kokumi-imparting agent | |
IL219888A0 (en) | Pyridine-pyridinone derivatives, preparation and therapeutic use thereof | |
HK1171225A1 (en) | Ethynyl derivatives | |
EP2515903A4 (en) | Compounds, preparations and uses thereof | |
EP2433502A4 (en) | Bitterness-suppressing agent | |
GB0900484D0 (en) | Therapeutic agent | |
HK1170277A1 (en) | Medicinal agent case | |
GB0915319D0 (en) | Combination medicament | |
GB0914738D0 (en) | Inhalers | |
HK1164861A1 (en) | Substituted 3-benzofuranyl-indol-2-one-3-acetamidopiperazine derivatives, preparation thereof, and therapeutic use thereof | |
GB0904904D0 (en) | Angiogenesis methods, medicaments and agents | |
AP2011006033A0 (en) | Simalikalactone E and use thereof as a medicament. | |
SI2421864T1 (en) | 1-pyrazološ4,3-cćisoquinoline derivatives, preparation thereof and therapeutic use thereof | |
AP2011005789A0 (en) | Sulfamoyl-phenyl-ureido benzamidine-derivatives asantimalarial agents. | |
GB0917792D0 (en) | Delivery agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |